Invention Grant
- Patent Title: Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
- Patent Title (中): 用于治疗糖尿病和代谢紊乱的杂环受体激动剂
-
Application No.: US13612451Application Date: 2012-09-12
-
Publication No.: US08975258B2Publication Date: 2015-03-10
- Inventor: Xin Chen , Peng Cheng , L. Edward Clemens , Jeffrey D. Johnson , Jingyuan Ma , Alison Murphy , Imad Nashashibi , Christopher J. Rabbat , Jiangao Song , Maria E. Wilson , Yan Zhu , Zuchun Zhao
- Applicant: Xin Chen , Peng Cheng , L. Edward Clemens , Jeffrey D. Johnson , Jingyuan Ma , Alison Murphy , Imad Nashashibi , Christopher J. Rabbat , Jiangao Song , Maria E. Wilson , Yan Zhu , Zuchun Zhao
- Applicant Address: US CA Newark
- Assignee: Cymabay Therapeutics, Inc.
- Current Assignee: Cymabay Therapeutics, Inc.
- Current Assignee Address: US CA Newark
- Agency: Foley & Larner LLP
- Main IPC: A61K31/50
- IPC: A61K31/50 ; C07D413/04 ; C07D401/04 ; C07D401/14 ; C07D417/14 ; C07D413/14 ; C07D417/04
Abstract:
Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active.
Public/Granted literature
- US20140024830A1 HETEROCYCLIC RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETES AND METABOLIC DISORDERS Public/Granted day:2014-01-23
Information query
